The molecular mechanisms of bacterial outer membrane vesicle formation
Project Number5R01AI075068-04
Contact PI/Project LeaderWHITELEY, MARVIN
Awardee OrganizationUNIVERSITY OF TEXAS AT AUSTIN
Description
Abstract Text
DESCRIPTION (provided by applicant): A large number of Gram-negative bacteria naturally produce extracellular membrane vesicles (MVs). These vesicles are derived from the outer membrane (OM) and contain OM and periplasmic proteins. MVs are an important component of bacterial virulence as they serve as trafficking vehicles for bacterial toxins to eukaryotic cells. In addition to trafficking toxins, our laboratory recently discovered that the opportunistic pathogen Pseudomonas aeruginosa utilizes MVs to traffic the cell-cell signaling molecule PQS between P. aeruginosa cells. Since PQS signaling is required for virulence, MVs are a critical component of P. aeruginosa pathogenicity. Although the roles of MVs in pathogenesis are clear, the molecular mechanism of MV formation is not currently understood. The goal of this proposal is to determine the molecular mechanism of MV formation in P. aeruginosa. To this end, a molecular model for MV formation has been developed, and three specific aims are proposed to test this model. These specific aims propose genetic, biochemical, and physiological techniques to exact a role for PQS (specific aim 1), lipopolysaccharide (specific aim 2), and pg-associated OM proteins (specific aim 3) in MV formation, with the ultimate goal of precisely defining the mechanism of MV formation. Due to their role in toxin and signal trafficking, understanding how MVs are produced will provide new insight into P. aeruginosa signaling and disease. Ultimately, understanding the molecular mechanism of MV formation may provide a novel target for antimicrobial development through development of technology to control MV production. Bacterial communication within a population is critical for pathogenicity of many bacteria, including the bacterium Pseudomonas aeruginosa. The goal of this project is to provide a fundamental understanding of how P. aeruginosa communicates, with the ultimate goal of devising ways to disrupt this communication.
National Institute of Allergy and Infectious Diseases
CFDA Code
855
DUNS Number
170230239
UEI
V6AFQPN18437
Project Start Date
15-July-2007
Project End Date
30-June-2012
Budget Start Date
01-July-2010
Budget End Date
30-June-2011
Project Funding Information for 2010
Total Funding
$357,398
Direct Costs
$265,135
Indirect Costs
$92,263
Year
Funding IC
FY Total Cost by IC
2010
National Institute of Allergy and Infectious Diseases
$357,398
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01AI075068-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01AI075068-04
Patents
No Patents information available for 5R01AI075068-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01AI075068-04
Clinical Studies
No Clinical Studies information available for 5R01AI075068-04
News and More
Related News Releases
No news release information available for 5R01AI075068-04
History
No Historical information available for 5R01AI075068-04
Similar Projects
No Similar Projects information available for 5R01AI075068-04